| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Accumulations of KIR+ T cells in the elderly
|
Pawelec, Graham
|
|
|
114 |
16 |
p. 3360-3361
|
article
|
| 2 |
Acute dasatinib exposure commits Bcr-Abl–dependent cells to apoptosis
|
Snead, Jennifer L.
|
|
|
114 |
16 |
p. 3459-3463
|
article
|
| 3 |
Bugs and marginal zone lymphoma of the ocular adnexae: is the future already here?
|
Ponzoni, Maurilio
|
|
|
114 |
16 |
p. 3499
|
article
|
| 4 |
Carfilzomib can induce tumor cell death through selective inhibition of the chymotrypsin-like activity of the proteasome
|
Parlati, Francesco
|
|
|
114 |
16 |
p. 3439-3447
|
article
|
| 5 |
Cerebrovascular reserve capacity is impaired in patients with sickle cell disease
|
Nur, Erfan
|
|
|
114 |
16 |
p. 3473-3478
|
article
|
| 6 |
Characterization of W1745C and S1783A: 2 novel mutations causing defective collagen binding in the A3 domain of von Willebrand factor
|
Riddell, Anne F.
|
|
|
114 |
16 |
p. 3489-3496
|
article
|
| 7 |
Chronic myeloid leukemia with p190BCR-ABL: prevalence, morphology, tyrosine kinase inhibitor response, and kinase domain mutation analysis
|
Pardanani, Animesh
|
|
|
114 |
16 |
p. 3502-3503
|
article
|
| 8 |
Chronic natural killer–cell lymphocytosis successfully treated with alemtuzumab
|
Chee, Cheng E.
|
|
|
114 |
16 |
p. 3500-3502
|
article
|
| 9 |
CLEC-2 is an essential platelet-activating receptor in hemostasis and thrombosis
|
May, Frauke
|
|
|
114 |
16 |
p. 3464-3472
|
article
|
| 10 |
CLEC … too!
|
Kunicki, Thomas J.
|
|
|
114 |
16 |
p. 3364-3365
|
article
|
| 11 |
Dominant role of CD47–thrombospondin-1 interactions in myeloma-induced fusion of human dendritic cells: implications for bone disease
|
Kukreja, Anjli
|
|
|
114 |
16 |
p. 3413-3421
|
article
|
| 12 |
Editorial Board
|
|
|
|
114 |
16 |
p. i
|
article
|
| 13 |
Epigenetic regulation of killer immunoglobulin–like receptor expression in T cells
|
Li, Guangjin
|
|
|
114 |
16 |
p. 3422-3430
|
article
|
| 14 |
First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia
|
Eichhorst, Barbara F.
|
|
|
114 |
16 |
p. 3382-3391
|
article
|
| 15 |
Histone hyperacetylation within the β-globin locus is context-dependent and precedes high-level gene expression
|
Fromm, George
|
|
|
114 |
16 |
p. 3479-3488
|
article
|
| 16 |
How I monitor residual disease in chronic myeloid leukemia
|
Radich, Jerald P.
|
|
|
114 |
16 |
p. 3376-3381
|
article
|
| 17 |
Lapalombella et al. Lenalidomide down-regulates the CD20 antigen and antagonizes direct and antibody-dependent cellular cytotoxicity of rituximab on primary chronic lymphocytic leukemia cells. Blood. 2008;112(13):5180–5189.
|
|
|
|
114 |
16 |
p. 3506
|
article
|
| 18 |
MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation
|
Figueroa, Maria E.
|
|
|
114 |
16 |
p. 3448-3458
|
article
|
| 19 |
One step back but 2 steps forward
|
Gribben, John G.
|
|
|
114 |
16 |
p. 3359-3360
|
article
|
| 20 |
Overexpression of Rheb2 enhances mouse hematopoietic progenitor cell growth while impairing stem cell repopulation
|
Campbell, Timothy B.
|
|
|
114 |
16 |
p. 3392-3401
|
article
|
| 21 |
RAS and CSF3R mutations in severe congenital neutropenia
|
Germeshausen, Manuela
|
|
|
114 |
16 |
p. 3504-3505
|
article
|
| 22 |
Reconstitution of protection against Aspergillus infection in chronic granulomatous disease (CGD)
|
Remijsen, Quinten
|
|
|
114 |
16 |
p. 3497
|
article
|
| 23 |
Response: Protecting against Aspergillus infection in CGD
|
Hakkim, Abdul
|
|
|
114 |
16 |
p. 3498
|
article
|
| 24 |
Response: Variability in the prevalence of Chlamydophila psittaci infection in patients with OAML
|
Stefanovic, Alexandra
|
|
|
114 |
16 |
p. 3499-3500
|
article
|
| 25 |
The doctor's dilemma: stimulating T cells
|
Vickers, Mark
|
|
|
114 |
16 |
p. 3361-3362
|
article
|
| 26 |
The microenvironment in mature B-cell malignancies: a target for new treatment strategies
|
Burger, Jan A.
|
|
|
114 |
16 |
p. 3367-3375
|
article
|
| 27 |
Therapeutic effect of CD137 immunomodulation in lymphoma and its enhancement by Treg depletion
|
Houot, Roch
|
|
|
114 |
16 |
p. 3431-3438
|
article
|
| 28 |
Through the looking glass
|
Alumkal, Joshi J.
|
|
|
114 |
16 |
p. 3363-3364
|
article
|
| 29 |
Tight control of MEK-ERK activation is essential in regulating proliferation, survival, and cytokine production of CD34+-derived neutrophil progenitors
|
Geest, Christian R.
|
|
|
114 |
16 |
p. 3402-3412
|
article
|
Journal description